MedTrace Logo

Ocular Comfort and Inflammation in Lid Hygiene Therapy

NCT02938078 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2020-08-20

No results posted yet for this study

Summary

The primary study objectives are: to evaluate (1) the change in ocular discomfort at 30 days and (2) the change in signs and symptoms of ocular surface disease in demodex-positive subjects beginning the use of Avenova.

Conditions

  • Blepharitis

Interventions

DEVICE

Avenova Lid Cleanser

Avenova lid cleanser is an FDA-cleared saline solution preserved with 0.01% pure hypochlorous acid.

Sponsors & Collaborators

  • NovaBay Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Minnesota Eye Consultants, P.A.

    lead INDUSTRY

Principal Investigators

  • Ahmad M Fahmy, OD · Minnesota Eye Consultants

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-08-24
Completion
2018-08-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02938078 on ClinicalTrials.gov